EX-4.1
from 8-K
160 pages
Inotiv, Inc., as the Issuer, the Guarantors Named Herein and U.S. Bank Trust Company, National Association, as Trustee and as Notes Collateral Agent, Indenture Dated as of September 13, 2024 $22,550,000 15.00% Senior Secured Second Lien Pik Notes Due 2027
12/34/56
EX-4.2
from S-8
4 pages
The Board of Directors of Bioanalytical Systems, Inc. (The "Company") Has Approved the Grant of Non-Qualified Stock Options to You. This Letter Will Serve as Notice of the Grant, Effective as of the Date of This Letter (The "Date of Grant"), and Subject to and Conditioned in All Respects on the Approval of the Shareholders of the Company, of an Option to Purchase (The "Option") 275,000 of the Common Shares of the Company (The "Option Shares") on the Terms and Conditions Set Forth Herein, and Upon Your Execution and Delivery to the Company of the Copy of This Letter Included Herein Will Constitute Our Agreement as to Those Terms. This Option Has Not Been Granted Under the Terms of the Company’s Employee Stock Option Plans, and Is Not a "Qualified" Stock Option as Defined by the Internal Revenue Service. You Are Urged to Consult With Your Tax Advisors Concerning the Tax Effect of the Grant and Exercise of This Option. 1. Option Price. the Purchase Price of the Option Shares Is $7.10 Per Share (The "Option Price")
12/34/56